Axxium Life, INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersDallas, TX
SAM.gov UEIEPWATCFTBAK8
Axxium develops proprietary AI-powered biologics using its Active Immunotherapy Medicine (AIM) platform, which trains the human body to generate personalized antibodies against chronic diseases. The company's lead candidate is an Alzheimer's prevention immunotherapy currently in Phase 3 clinical trials. Axxium has conducted over 10 human clinical trials with more than 4,200 participants and reports that over 98% of patients generated antibodies in response to the AIM technology.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Axxium Life, INC | Dallas | TX | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.